February 10, 2023 12:10 PM ESTUpdated February 13, 09:18 AM
Pharma
FDA+

Japan can­cels 140M dose or­der for No­vavax Covid vac­cine amid 'low­er than ex­pect­ed' de­mand

Katherine Lewin

News Reporter

Japan has can­celed an or­der for more than 140 mil­lion dos­es of No­vavax’s Covid-19 vac­cine, Take­da re­vealed in an SEC fil­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sanofi to pay $125M up­front for two im­munol­o­gy drugs from lit­tle-known biotech

US drugs re­ly heav­i­ly on in­gre­di­ents made over­seas, new re­port shows

Sarep­ta los­es CMO to RNA edit­ing up­start; An­oth­er wave of per­son­nel moves at Dyne

Biotech seed rounds sink to low­est lev­el in years as in­dus­try slump drags on

Ex­clu­sive: VelaV­i­go inks an­oth­er US biotech deal as Chi­na drug de­vel­op­ment scene booms

sponsored

New York-based part­ner­ship sets the stan­dard for ex­pand­ing clin­i­cal tri­al ac­cess for un­der­served and di­verse ...

A service from the Financial Times